SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBridgepoint Regulatory News (BPT)

Share Price Information for Bridgepoint (BPT)

Share Price is delayed by 15 minutes
Get Live Data
244.40    5.60 (2.35%)
Bid:
244.60
Ask:
245.00
Spread: 0.40 (0.164%)
Market Cap: £2.14b
BPT Live PriceLast checked at - London Stock Exchange

Intraday Bridgepoint Share Chart

Share Buyback Programme

24 Jan 2023 07:00

RNS Number : 6072N
Bridgepoint Group plc
24 January 2023
 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

Bridgepoint Group plc ("Bridgepoint" or the "Company")

Share Buyback Programme

 

24 January 2023

 

Bridgepoint today announces a share buyback programme of up to £50 million (the "Buyback Programme"). The Buyback Programme will run from and including 24 January 2023 and is expected to be completed on or before 30 September 2023.

 

Bridgepoint's strategy and growth agenda, including its approach to diversification, remains unchanged. This Buyback Programme reflects the Board's confidence in Bridgepoint's fundamental value and long-term prospects, at a time when short-term market dislocations mean that there is value in allocating capital to repurchase the Company's shares. The Buyback Programme represents a targeted use of below 20% of the Company's current net cash given the value the Board sees in the current valuation.

 

Details of the Buyback Programme

 

Bridgepoint has entered into an arrangement with J.P. Morgan Securities plc ("JP Morgan Securities") in relation to the purchase by JP Morgan Securities, as riskless principal, of ordinary shares in Bridgepoint (the "Shares").

 

Any purchases of Shares pursuant to the Buyback Programme will be effected within certain pre-set parameters. These arrangements are in accordance with Bridgepoint's general authority to repurchase up to 82,326,877 Shares granted at its Annual General Meeting held on 12 May 2022 (the "2022 AGM"), Chapter 12 of the Listing Rules, and those provisions of Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). The number of ordinary shares to be purchased under the Buyback Programme will not exceed 82,326,877 Shares and is therefore within the 2022 AGM approved limit. The authority granted at the 2022 AGM expires at the earlier of the close of business on 31 July 2023 and the conclusion of the 2023 annual general meeting, and Bridgepoint expects to seek renewal of the authority to buy back shares at the 2023 annual general meeting. 

 

Details of the authority granted at the 2022 AGM can be found on our website at https://www.bridgepointgroupplc.com/shareholder-centre/annual-general-meeting.

 

The aggregate purchase price to be paid pursuant to the Buyback Programme is £50 million, and any Shares purchased will be cancelled.

 

The sole purpose of these share purchases is to reduce the Company's share capital.

 

 

ENQUIRIES

 

Bridgepoint

 

Analysts and investors

Adam Key

adam.key@bridgepoint.eu

+44 7833 748010

 

Media

Christian Jones / James Murray

christian.jones@bridgepoint.eu james.murray@bridgepoint.eu

+44 20 7034 3500

 

Finsbury Glover Hering (Public Relations Adviser to Bridgepoint)

 

Charles O'Brien / +44 20 7251 3801 / +44 7825 043 656

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

bridgepoint@fgsglobal.com

 

Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBJMPTMTMTBBJ
Date   Source Headline
9th Jun 20267:00 amRNSHolding(s) in Company
12th May 20264:15 pmRNSResult of AGM
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTotal Voting Rights
26th Mar 202610:00 amRNSAnnual Report and Accounts and Notice of AGM
23rd Mar 202610:45 amRNSIssue of Equity and Total Voting Rights
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 202612:30 pmRNSIssue of Equity and Total Voting Rights
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 202611:30 amRNSIssue of Equity
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.